TR201818614T4 - Bir Kromatografi Kolonunun Rejenerasyonuna Yönelik Yöntem - Google Patents

Bir Kromatografi Kolonunun Rejenerasyonuna Yönelik Yöntem Download PDF

Info

Publication number
TR201818614T4
TR201818614T4 TR2018/18614T TR201818614T TR201818614T4 TR 201818614 T4 TR201818614 T4 TR 201818614T4 TR 2018/18614 T TR2018/18614 T TR 2018/18614T TR 201818614 T TR201818614 T TR 201818614T TR 201818614 T4 TR201818614 T4 TR 201818614T4
Authority
TR
Turkey
Prior art keywords
chromatography column
regeneration
invention includes
present
cation exchange
Prior art date
Application number
TR2018/18614T
Other languages
English (en)
Inventor
Burg Josef
Reichert Klaus
Schroth Axel
Schurig Hartmut
Wessner Axel
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39119089&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR201818614(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of TR201818614T4 publication Critical patent/TR201818614T4/tr

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/20—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the conditioning of the sorbent material
    • B01D15/203—Equilibration or regeneration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/362—Cation-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J49/00—Regeneration or reactivation of ion-exchangers; Apparatus therefor
    • B01J49/50—Regeneration or reactivation of ion-exchangers; Apparatus therefor characterised by the regeneration reagents
    • B01J49/53—Regeneration or reactivation of ion-exchangers; Apparatus therefor characterised by the regeneration reagents for cationic exchangers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J49/00—Regeneration or reactivation of ion-exchangers; Apparatus therefor
    • B01J49/60—Cleaning or rinsing ion-exchange beds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]

Abstract

Mevcut buluş, bir katyon değişim kromatografisi kolonu rejenerasyonuna yönelik bir yöntem içerir.
TR2018/18614T 2007-07-17 2008-07-15 Bir Kromatografi Kolonunun Rejenerasyonuna Yönelik Yöntem TR201818614T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07013960 2007-07-17

Publications (1)

Publication Number Publication Date
TR201818614T4 true TR201818614T4 (tr) 2019-01-21

Family

ID=39119089

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2018/18614T TR201818614T4 (tr) 2007-07-17 2008-07-15 Bir Kromatografi Kolonunun Rejenerasyonuna Yönelik Yöntem

Country Status (20)

Country Link
US (2) US7846336B2 (tr)
EP (1) EP2173450B1 (tr)
JP (1) JP5025796B2 (tr)
KR (1) KR101164734B1 (tr)
CN (1) CN101754789B (tr)
AR (2) AR067536A1 (tr)
AU (1) AU2008277888B2 (tr)
BR (1) BRPI0814118B1 (tr)
CA (1) CA2692726C (tr)
CL (1) CL2008002054A1 (tr)
ES (1) ES2704013T3 (tr)
HR (1) HRP20182171T1 (tr)
IL (1) IL202942A (tr)
PE (1) PE20090448A1 (tr)
PL (1) PL2173450T3 (tr)
RU (1) RU2464066C2 (tr)
SI (1) SI2173450T1 (tr)
TR (1) TR201818614T4 (tr)
TW (1) TWI395619B (tr)
WO (1) WO2009010271A2 (tr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR067536A1 (es) * 2007-07-17 2009-10-14 Hoffmann La Roche Metodo para obtener una eritropoyetina mono-pegilada en una forma sustancialmente homogenea
CL2008002053A1 (es) * 2007-07-17 2009-05-22 Hoffmann La Roche Metodo para la purificacion de una eritropoyetina monopeguilada (epompeg) que consiste en proporcionar una solucion que contiene eritropoyetina mono, poli y no peguilada y hacerla pasar por dos pasos de cromatografia de intercambio cationico y metodo para producir epo mpeg que incluye metodo de purificacion.
EA028065B1 (ru) * 2009-04-01 2017-10-31 Рациофарм Гмбх Способ очистки рекомбинантного фсг
WO2011038894A1 (en) * 2009-10-01 2011-04-07 F. Hoffmann-La Roche Ag Protein a chromatography
AU2010302662B2 (en) 2009-10-01 2015-11-26 F. Hoffmann-La Roche Ag Multistep final filtration
JP5735650B2 (ja) * 2010-09-14 2015-06-17 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ Ｐｅｇ化エリスロポエチンを精製するための方法
WO2012084828A1 (en) 2010-12-21 2012-06-28 F. Hoffmann-La Roche Ag Chromatography equipment characterization
CN103115998B (zh) * 2013-02-04 2014-10-15 田晓露 一种离子色谱保护柱柱芯处理再利用方法
CN104368402A (zh) * 2013-08-13 2015-02-25 内蒙古蒙牛乳业（集团）股份有限公司 一种氨基酸分析用的阳离子交换树脂的再生方法
ES2737078T3 (es) * 2013-09-04 2020-01-10 Emd Millipore Corp Cromatografía de Proteína A
CA3067735A1 (en) 2017-08-17 2019-02-21 Just Biotherapeutics, Inc. Method of purifying glycosylated protein from host cell galectins and other contaminants
CN112933660A (zh) * 2020-09-11 2021-06-11 石家庄新奥环保科技有限公司 一种离子色谱保护柱再生方法
CN115032317B (zh) * 2022-06-29 2024-03-26 科兴生物制药股份有限公司 重组人***的检测方法

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5118796A (en) * 1987-12-09 1992-06-02 Centocor, Incorporated Efficient large-scale purification of immunoglobulins and derivatives
FR2646438B1 (fr) 1989-03-20 2007-11-02 Pasteur Institut Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration
EP0747485B1 (en) 1989-11-06 1998-12-02 Cell Genesys, Inc. Production of proteins using homologous recombination
JP3501286B2 (ja) 1989-12-22 2004-03-02 アプライド リサーチ システムズ，エーアールエス ホールディング ナームロゼ ベノートスハップ 一定の細胞系又は微生物の内因性遺伝子の発現特徴の変性のための方法
FR2656531B1 (fr) 1989-12-29 1992-04-24 Sanofi Sa Promoteur artificiel pour l'expression de proteines dans le levure.
JPH04218000A (ja) 1990-02-13 1992-08-07 Kirin Amgen Inc 修飾ポリペプチド
JP2826362B2 (ja) 1990-02-13 1998-11-18 三井化学株式会社 オレフィン重合用固体触媒の製造方法、オレフィン重合用固体触媒およびオレフィンの重合方法
JP3051145B2 (ja) * 1990-08-28 2000-06-12 住友製薬株式会社 新規なポリエチレングリコール誘導体修飾ペプチド
US5643567A (en) * 1990-12-04 1997-07-01 Board Of Regents, The University Of Texas System Methods for the suppression of neu mediated tumors by adenoviral E1A and SV40 large T antigen
CH686212A5 (de) 1992-03-07 1996-02-15 Buehler Ag Geb Verfahren und Vorrichtung zur Manipulation und Portionieren von langen Teigwaren.
DE4118912C1 (tr) 1991-06-08 1992-07-02 Biotest Pharma Gmbh, 6072 Dreieich, De
EP0536447A1 (en) 1991-10-11 1993-04-14 Koninklijke Emballage Industrie Van Leer B.V. Exposure meter for use with induction heat sealing of containers
US5968502A (en) * 1991-11-05 1999-10-19 Transkaryotic Therapies, Inc. Protein production and protein delivery
US5641670A (en) 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
NZ245015A (en) 1991-11-05 1995-12-21 Transkaryotic Therapies Inc Delivery of human growth hormone through the administration of transfected cell lines encoding human growth hormone, which are physically protected from host immune response; the transfected cells and their production
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
CA2140002A1 (en) * 1992-07-13 1994-01-20 Jay Stout A chemical method for selective modification of the n- and/or c-terminal amino acid .alpha.-carbon reactive group of a recombinant polypeptide or a portion thereof
US5264555A (en) 1992-07-14 1993-11-23 Enzon, Inc. Process for hemoglobin extraction and purification
TW402639B (en) 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
US5437989A (en) * 1992-12-30 1995-08-01 Hoffmann-La Roche Inc. Alcohol/aldehyde dehydrogenase from Gluconobacter oxydans DSM 4025 FERM BP-3812
US5932462A (en) * 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
IL118201A (en) * 1995-05-11 2004-12-15 Roche Diagnostics Gmbh Preparation comprising a protein with human erythropoietin activity which is free of serum and non-recombinant mammalian protein and process for the preparation thereof
DE19535571A1 (de) 1995-09-14 1997-03-20 Boehringer Mannheim Gmbh Pharmazeutische Kombinationspräparate und deren Verwendung zur Behandlung von Hämodialysepatienten
TWI240627B (en) 1996-04-26 2005-10-01 Chugai Pharmaceutical Co Ltd Erythropoietin solution preparation
EP0885613A1 (de) * 1997-06-21 1998-12-23 Roche Diagnostics GmbH Verwendung von modifizierten Hämoglobinen zur Behandlung von Anämien und Kombinationspräparate umfassend Erythropoietin und modifiziertes Hämoglobin
WO1998058661A1 (en) 1997-06-23 1998-12-30 Novo Nordisk A/S Use of fviia for the treatment of bleedings in patients with a normal blood clotting cascade and normal platelet function
US7101838B2 (en) 1997-08-05 2006-09-05 The Trustees Of Columbia University In The City Of New York Method to prevent accelerated atherosclerosis using (sRAGE) soluble receptor for advanced glycation endproducts
DE19734293A1 (de) * 1997-08-08 1999-02-11 Boehringer Mannheim Gmbh Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen
BR9917606A (pt) 1998-11-06 2002-12-31 Bio Sidus S A Procedimento para a purificação de eritropoetina humana recombinante a partir de sobrenadantes de cultivo de células e eritropoetina humana recombinante obtida com tal procedimento
DK1147134T3 (da) 1999-01-26 2007-02-05 Neurosearch As Hidtil ukendte kaliumkanaler og gener, der koder for disse kaliumkanaler
ATE246202T1 (de) 1999-01-29 2003-08-15 Hoffmann La Roche Gcsf konjugate
RU2215748C2 (ru) * 1999-04-09 2003-11-10 Сентро Де Инмунология Молекулар Способ получения рекомбинантного эритропоэтина человека и полученный эритропоэтин, фармацевтическая композиция
US6583273B1 (en) * 1999-05-10 2003-06-24 Ciba Specialty Chemicals Corporation Azo dyes, process for their preparation and their use for dyeing or printing natural or synthetic materials
DE19930177B4 (de) 1999-06-30 2007-02-08 Nikolai Vladimirovich Bovin Intermolekular assoziierende Verbindungen und deren Verwendung
PE20010288A1 (es) 1999-07-02 2001-03-07 Hoffmann La Roche Derivados de eritropoyetina
CZ299516B6 (cs) * 1999-07-02 2008-08-20 F. Hoffmann-La Roche Ag Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
EP1252192B1 (en) * 2000-02-11 2006-08-16 MERCK PATENT GmbH Enhancing the circulating half-life of antibody-based fusion proteins
US6586398B1 (en) 2000-04-07 2003-07-01 Amgen, Inc. Chemically modified novel erythropoietin stimulating protein compositions and methods
US20050100991A1 (en) * 2001-04-12 2005-05-12 Human Genome Sciences, Inc. Albumin fusion proteins
WO2001087329A1 (en) * 2000-05-15 2001-11-22 F. Hoffmann-La Roche Ag Liquid pharmaceutical composition containing an erythropoietin derivate
MXPA03005406A (es) * 2000-12-20 2003-09-25 Hoffmann La Roche Conjugados de eritropoyetina.
US6930086B2 (en) 2001-09-25 2005-08-16 Hoffmann-La Roche Inc. Diglycosylated erythropoietin
US6797299B2 (en) 2002-02-05 2004-09-28 Great Wall Enterprise Co., Ltd. Desalting method for nutritional supplements with animal protein
SE526227C2 (sv) * 2002-05-15 2005-08-02 North China Pharmaceutical Group Metod för rening av rekombinant humant serumalbumin
AU2003246486A1 (en) 2002-07-19 2004-02-09 Cangene Corporation Pegylated erythropoietic compounds
KR100608415B1 (ko) 2002-07-24 2006-08-02 에프. 호프만-라 로슈 아게 폴리알킬렌 글리콜산 첨가제
HUE033623T2 (en) * 2002-09-11 2017-12-28 Genentech Inc protein purification
US7610156B2 (en) * 2003-03-31 2009-10-27 Xencor, Inc. Methods for rational pegylation of proteins
US20050008649A1 (en) 2003-06-02 2005-01-13 University Of Miami Chimeric molecules and methods of use
SE0401951D0 (sv) 2004-07-29 2004-07-29 Amersham Biosciences Ab Chromatography method
EP1885488B1 (en) * 2005-05-24 2015-07-08 GE Healthcare Bio-Sciences AB Regeneration of a chromatography matrix
TWI391399B (zh) * 2005-05-25 2013-04-01 Hoffmann La Roche 測定溶離多肽之鹽濃度之方法
US20070072795A1 (en) 2005-09-28 2007-03-29 Anton Haselbeck Treatment of neurodegenerative disorders
CA2625208A1 (en) * 2005-10-04 2007-04-12 Zymogenetics, Inc. Production and purification of il-29
WO2008010061A2 (en) 2006-07-17 2008-01-24 Glenmark Pharmaceuticals S.A. 3-azabicyclo [3.1.0] hexane vanilloid receptor ligands, pharmaceutical compositions containing them, and processes for their preparation
CL2008002053A1 (es) * 2007-07-17 2009-05-22 Hoffmann La Roche Metodo para la purificacion de una eritropoyetina monopeguilada (epompeg) que consiste en proporcionar una solucion que contiene eritropoyetina mono, poli y no peguilada y hacerla pasar por dos pasos de cromatografia de intercambio cationico y metodo para producir epo mpeg que incluye metodo de purificacion.
AR067536A1 (es) * 2007-07-17 2009-10-14 Hoffmann La Roche Metodo para obtener una eritropoyetina mono-pegilada en una forma sustancialmente homogenea

Also Published As

Publication number Publication date
US20090101585A1 (en) 2009-04-23
RU2464066C2 (ru) 2012-10-20
AU2008277888B2 (en) 2012-08-16
PE20090448A1 (es) 2009-04-18
TW200911373A (en) 2009-03-16
BRPI0814118B1 (pt) 2019-04-09
BRPI0814118A2 (pt) 2015-02-03
AR110693A2 (es) 2019-04-24
HRP20182171T1 (hr) 2019-02-22
US7846336B2 (en) 2010-12-07
AU2008277888A1 (en) 2009-01-22
TWI395619B (zh) 2013-05-11
WO2009010271A2 (en) 2009-01-22
RU2010105312A (ru) 2011-08-27
KR101164734B1 (ko) 2012-07-12
AR067536A1 (es) 2009-10-14
KR20100037145A (ko) 2010-04-08
US8795533B2 (en) 2014-08-05
JP5025796B2 (ja) 2012-09-12
WO2009010271A3 (en) 2009-04-02
CN101754789A (zh) 2010-06-23
CA2692726A1 (en) 2009-01-22
CN101754789B (zh) 2013-10-23
CL2008002054A1 (es) 2009-05-29
US20110065903A1 (en) 2011-03-17
SI2173450T1 (sl) 2019-02-28
EP2173450B1 (en) 2018-10-31
JP2010533845A (ja) 2010-10-28
IL202942A (en) 2016-10-31
EP2173450A2 (en) 2010-04-14
PL2173450T3 (pl) 2019-03-29
ES2704013T3 (es) 2019-03-13
CA2692726C (en) 2015-02-24

Similar Documents

Publication Publication Date Title
TR201818614T4 (tr) Bir Kromatografi Kolonunun Rejenerasyonuna Yönelik Yöntem
HK1221234A1 (zh) 通過陽離子交換層析進行的抗體純化
ATE490254T1 (de) Imidazoä1,2-aüpyridin-verbindungen als vegf-r2- hemmer
BRPI0923786A2 (pt) compostos 5,6-dihidro-6-fenilbenzo(f) isoquinolina-2- amina substituidos
BRPI0815717A2 (pt) Compostos de imidazopirazina.
DK1869065T3 (da) Fremgangsmåde til kromatografi med svag opdeling
CR10353A (es) Nuevos compuestos.
BRPI0811189A2 (pt) Ferramenta de nivelação composta.
EA200971068A1 (ru) Триазолиламинопиримидиновые соединения
BRPI0911615A2 (pt) grampo para coluna de ascensão.
CO6241120A2 (es) (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS.
EA200702543A1 (ru) Циклопентадиенильно-флуоренильные лиганды с углеродными мостиками
BRPI0916395A2 (pt) compostos de 1,6-di-hidro-2h-3-oxa-6-aza-as-indaceno
DK2212041T3 (da) Værktøjssystem, især til notstødning
DK2000383T3 (da) Fjederarrangement til et fartøj, især et skinnefartøj
BRPI1011720A2 (pt) compostos de 1,1,1- tri-flúor-2 hidróxi-propila.
FR2924340B1 (fr) Procede de maquillage des ongles.
BRPI0716205A2 (pt) Polimorfo de brometo de (r)-3(2-hidróxi-2,2-difenil-acetóxi)-1-(isoxazol-3-ilcarb amoil-metil)-1-azonia-biciclo-[2.2.2]octano
CL2008001377A1 (es) Proceso para la preparacion de compuestos derivados de tetrahidroquinolinilo.
DK2280961T3 (da) 1,5-diphenyl-pyrrolidin-2-on-forbindelser som cb-1-ligander
BRPI0811781A2 (pt) Compostos de ((fenil) imidazolil)metilquinolinila terapêuticos.
ITRM20050333A1 (it) Apparato per la produzione energetica.
DK2197479T3 (da) Inositol-pyrophosphater til bestemmelse af exozytotisk kapacitet
ITTV20060137A1 (it) Servo equilibrio per veicoli.
ES1068191Y (es) Cabezal posicionador, para centros de mecanizado